BioStem Technologies Inc

Public

United StatesHealthcarehttps://biostemtechnologies.com/

BioStem Technologies Inc is now publicly traded

The data on this page reflects BioStem Technologies Inc's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Jun 3, 2026

Total Funding Raised

$2.5M

Company Overview

BioStem Technologies Inc is a regenerative medicine company that develops, manufactures, and commercializes placental-derived allografts for advanced wound care.

Sector

Healthcare

AI Layer

Non-AI

Keywords

advanced wound careplacental allograftsregenerative medicineskin substitutesbiologicsamniotic tissuechronic wound treatmenttissue engineeringcontract development and manufacturingCDMOocular allograftAATB accreditedFDA registered facilityperinatal tissuegovernment contractsFederal Supply ScheduleFSS

BioStem Technologies Inc Comparables

Compare BioStem Technologies Inc with similar companies based on industry and business-model similarity.

BioStem Technologies Inc comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Skye Biologics Holdings	86%
Merakris Therapeutics	75%
CTM Biomedical	75%

View all Comparables

BioStem Technologies Inc Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	Jun 3, 2026

View all Funding Rounds

Key People

Founding team and executive leadership

Andrew VanVurst

Chief Operating Officer Co Founder, Chief Operating Officer

Founding Team

Jason Matuszewski

Chief Executive Officer, Co-Founder

Founding Team

Brandon Poe

Chief Financial Officer, Member Board Of Directors, Audit Committee Chair

Executive Team

BioStem Technologies Inc Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

BioStem Technologies Inc Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersUnited States

Employee Range62

Year Founded2009

Last FundingJun 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.